Skip to main content
Donald Small, MD, Oncology, Baltimore, MD

DonaldSmallMD

Oncology • Baltimore, MD

Professor of Oncology, Professor of Pediatrics, Johns Hopkins University School of Medicine; Director, Division of Pediatric Oncology, Kyle Haydock Professor of Oncology

Join to view full profile

Dr. Small is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Small's full profile

Already have an account?

  • Office

    600 N Wolfe St
    Baltimore, MD 21287
    Phone+1 410-955-6132
    Fax+1 410-955-8897

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 1987 - 1990
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Pediatrics, 1985 - 1987
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1985

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1987 - 2025
  • FL State Medical License
    FL State Medical License 2014 - 2016

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Publications & Presentations

PubMed

Abstracts/Posters

  • Dissociation of the DNMT3A-HDAC1 Repressor Complex Induces PD-L1 Expression
    Donald Small, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • DOCK2 Expression Affects Leukemogenesis and Disease Progression in a Murine Model of FLT3/ITD Acute Myeloid Leukemia
    Donald Small, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • FLT3 Inhibitor Correlative Laboratory Assays Impact Outcomes in KMT2A-Rearranged Infant Acute Lymphoblastic Leukemia (ALL) Patients Treated with Lestaurtinib: AALL0631...
    Donald Small, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Combinatorial Approaches to Overcome Plasma Protein Inhibition of FLT3 Tyrosine Kinase Inhibitors 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Scientists Identify 'Mutation Accelerator' in Gene Mutation Linked to Common Adult Leukemia
    Scientists Identify 'Mutation Accelerator' in Gene Mutation Linked to Common Adult LeukemiaJune 10th, 2015

External Links

Dr. Donald Small, Dr. Donald Small, MD, Dr. D Small